RHYTHM PHARMACEUTICALS, INC. Increase (Decrease) in Restricted Cash for Operating Activities
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Increase (Decrease) in Restricted Cash for Operating Activities of $225.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2018-03-12
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in restricted cash for operating activities for fiscal 2015 was $225.00K.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 12 month |
|---|---|
| 2015-12-31 | $225.00K 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |